Morepen Laboratories share news and announcements
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Last close ₹123.54up ₹5.87 (4.99%)BSE ₹123.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹117.67.
52-week range of traded prices to 23 Oct 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,769 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 4 Aug 2026
- 48.2
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹26 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 59.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 5.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.16%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 4 Aug 2026
- 11.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹26 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 9.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 4 Aug 2026
- 10.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day.
- 50,63,581
Morepen Laboratories board meetings
128 filed, newest first. Page 3 of 3.
Nov 2011
8 Nov · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on November 08, 2011 to Consider and take on record interalia the unaudited Financial Results of the Company for the Quarter ended on September 30, 2011. The Company has now informed the Exchange that the said meeting of the Board of Directors will now be held on November 09, 2011 to consider and take on record inter alia the Un-audited Financial Results of the Company for the quarter ended on September 30, 2011.
Oct 2011
31 Oct · Board meeting
To Consider and take on record interalia the unaudited Financial Results of the Company for the Quarter ended on September 30, 2011.
Jul 2011
29 Jul · Board meeting
To consider and take on record inter alia the Un-audited Financial Results of the Company for the quarter ended on June 30, 2011.
May 2011
10 May · Board meeting
To consider and take on record inter alia the Audited Financial Results of the Company for the financial year ended on March 31, 2011.
Jan 2011
31 Jan · Board meeting
To consider and take on record inter alia the un-audited Financial Results of the Company for the quarter ended on December 31, 2010.
Oct 2010
18 Oct · Board meeting
To consider and take on record interalia the Un audited Financial Results of the Company for the quarter ended on September 30, 2010.
Jul 2010
20 Jul · Board meeting
To consider and take on record inter alia the un-audited Financial Results of the Company for the quarter ended on June 30, 2010.
May 2010
6 May · Board meeting
To consider and take on record inter alia the Audited Financial Results of the Company for the financial year ended on March 31, 2010.
Jan 2010
12 Jan · Board meeting
Meeting on 21 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
21 Oct · Board meeting
Meeting on 27 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Aug 2009
12 Aug · Board meeting
Pursuant to the order dated 4th August, 2009 of the Hon'ble High Court of Himachal Pradesh at Shimla approving the Scheme of Compromise and Arrangement, under Section 391-394 of Companies Act, 1956, the Board of Directors in its meeting held on 12th August, 2009 has made an allotment of 9,24,90,413 (Nine Crores twenty four lacs ninety thousand four hundred and thirteen only) equity shares of Rs.2/- each to the Fixed Depsit holders of the company. These shares have been allotted at a price of Rs.11.32 per share which has been arrived at in accordance with the terms of the approved scheme and the pricing formula specified in SEBI (DIP) Guidelines12 Aug · Board meeting
To make the allotment of Equity Shares of Rs.2/- each, pursuant to a Scheme of compromise or arrangement under section 391 to 394 of Companies Act 1956 approved on August 04, 2009 by the Hon'ble High Court of Himachal Pradesh, to the Fixed Deposit Holders of the Company.
Jul 2009
17 Jul · Board meeting
Meeting on 27 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
May 2009
18 May · Board meeting
To consider and take on record inter alia the Audited Financial Results of the Company for the year ended on March 31, 2009.
Jan 2009
13 Jan · Board meeting
Meeting on 19 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
13 Oct · Board meeting
To consider and take on record inter alia the Un-audited financial results of the Company for the quarter/half year ended September 30, 2008.
Jul 2008
15 Jul · Board meeting
Meeting on 24 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
May 2008
6 May · Board meeting
To consider and take on record inter alia the Audited financial results of the Company for the Financial Year ended March 31, 2008.
Jan 2008
7 Jan · Board meeting
Meeting on 15 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Dec 2007
28 Dec · Board meeting
The Company has approved the following in the Meeting of its Board of Directors held on December 28, 2007: 1) Allotment of 385,30,000 Equity Shares to GL India Mauritius III Ltd.; 2) Allotment of 1,35,20,000 Warrants convertible into Equity Shares to GL India Mauritius III Ltd.; and 3) Allotment of 10,00,00,000 Equity Shares on Conversion of 1000 outstanding Warrants to Promoters26 Dec · Board meeting
To consider the following:- (1) Allotment of 385,30,000 Equity Shares and 1,35,20,000 Warrants convertible into Equity Shares to GL India Mauritius III Ltd. (2) Conversion of 1000 outstanding warrants into 1,00,00,000 Equity Shares to Promoters.
Oct 2007
17 Oct · Board meeting
Company had informed the Exchange regarding the Meeting of the Board of Directors of the Company scheduled to be held on October 17, 2007 to consider and take on record inter alia the Un-audited financial results of the Company for the quarter /half year ended September 30, 2007. The Company has now informed the Exchange that the Meeting has been adjourned to be held on October 18, 2007 for consideration of the same business.8 Oct · Board meeting
To consider and take on record inter alia the Un-audited financial results of the Company for the quarter/half year ended September 30, 2007.
Jul 2007
10 Jul · Board meeting
Meeting on 17 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Apr 2007
23 Apr · Board meeting
To consider and take on record inter alia the Un-audited financial results of the Company for the quarter/year ended March 31, 2007.
Mar 2007
16 Mar · Board meeting
In furtherance to implementation of CDR package, the Board of Directors in its meeting, held on March 15, 2007, has approved the following investment in the company for settlement of Debts, Capital expenditure and working capital : (1) Issuance of Equity Share Capital amounting to Rs.150 Crore (14.99% of the Equity Capital) to Avenue Asia Fund and raising Rs.100 Crore by way of debt from an International Bank (New Investors); (2) Issuance of Warrants with right to subscribe to equity shares (upto 10% of Equity Capital) to new Investors; (3) Issuance of Equity Share Capital of upto Rs. 17 Crore to existing banks / Financial Institutions as part of settlement package; and (4) Issuance of 0.01% Optionally Convertible Preference shares amounting to Rs.90 Crore to Banks/Financial Institutions / existing preference shareholders as part of settlement package8 Mar · Board meeting
Convening the Board Meeting on 15.03.2007 to consider issuance of Equity Shares/Securities/Warrants to Investors, Banks and Financial Institutions on Preferential allotment basis. Further the Company has informed the Exchange that this matter would be considered by the Board, pursuant to the CDR package approved by the Lenders.
Jan 2007
25 Jan · Board meeting
Meeting on 31 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”